All The Most Important News and Updates form the International Association for the Study of Lung Cancer 19th World Conference –…

All The Most Important News and Updates form the International Association for the Study of Lung Cancer 19th World Conference –…
All The Most Important Pharmaceutical News Stories Of The Week – July 2018 – Week #4 Catalyst Biosciences Announces Positive…
All The Most Important Pharmaceutical News Stories Of The Week – July 2018 – Week #2 FDA Grants Priority Review…
All The Most Important Pharmaceutical News Stories Of The Week – June 2018 – Week #4 New long-term data confirm…
All The Most Important News and Updates form ASCO 2018 Preliminary Data for NKTR-214 in Combination with Opdivo (nivolumab) for…
All The Most Important Pharmaceutical News Stories Of The Week – May 2018 – Week #3 Lynparza tablets receive EU…
All The Most Important Pharmaceutical News Stories Of The Week – May 2018 – Week #2 Kymriah® (tisagenlecleucel), first-in-class CAR-T…
All The Most Important Pharmaceutical News Stories Of The Week – March 2018 – Week #4 Seattle Genetics Announces FDA…
All The Most Important News and Updates form ASCO Genitourinary Cancers Symposium 2018 Phase III IMmotion151 study showed Roche’s TECENTRIQ®…
Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH) November 2,…
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies selectively targeting genetic drivers of cancer November 14, 2017…
Pfizer Announces Outcome of FDA Advisory Committee Meeting for Sutent® In Patients at High Risk of Recurrent Renal Cell Carcinoma…
1 September 2016 Roche has announced positive results for TECENTRIQ® from the Phase III study, which met its co-primary endpoints…